Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01458067 |
| Title | A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | New Haven | Connecticut | 06520 | United States | Details | |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Salt Lake City | Utah | 84112 | United States | Details | |
| GSK Investigational Site | Seoul | 110-744 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 120/752 | Korea, Republic of | Details | ||
| GSK Investigational Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details | |
| GSK Investigational Site | London | W1G 6AD | United Kingdom | Details |